Article · 29 Aug 2026
Conference abstract
Live attenuated varicella vaccine: A new effective adjuvant weapon in the battlefield against severe resistant psoriasis, a randomized controlled trial
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background: Treatment of resistant psoriasis may be difficult and immunotherapy was first reported in the treatment of psoriasis in the 1970's, using live measles vaccine with a high cure rate. Objective: To evaluate the efficacy and safety of live attenuated varicella vaccine as an adjuvant immunotherapeutic modality in treatment of severe resistant psoriasis. Methods: This randomized, placebo controlled, double blinded study included 35 patients with severe resistant psoriasis. Patients were randomly divided into 2 groups; group A (18 patients) and group B (17 patients) who all received cyclosporine at a daily dose of 2.5 mg/kg/day. In addition, group A received 4 doses of live attenuated varicella vaccine once/3 weeks, simultaneously group B received 4 doses of subcutaneous saline in the same pattern as group A. Clinical assessment was based on the psoriasis area and severity index score calculation at each visit. Final patient's response (week 12) was rated according to the physician global assessment. Results: Group A showed significantly higher % of improvement in their PASI score (mean, 95% CI 81.83, 69.05-94.60) than group B (mean, 95% CI 50.12, 34.58-65.66) (P=0.002). Group A achieved a more significant improvement in their score evaluations than group B. 83.3% (15/18) of group A achieved a meaningful improvement (≥50% improvement) versus 47.1% (8/17) of group B (P=0.024). Adverse events were minimal and no drug discontinuation was needed. Conclusion: Taking into consideration some precautions, combined live attenuated varicella vaccine and relatively low dose cyclosporine demonstrated positive responses, and the treatment was well tolerated.
Keywords
Subjects
Vaccines & ImmunisationAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Vaccines & Vaccination.
Article · 29 Aug 2026
Advances in Adjuvant Development for Enhanced Vaccine Performance and Long-Term Immune Protection
Article · 20 Jun 2026
Herd Immunity and Its Role in Controlling Infectious Diseases
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Vaccines & Vaccination
- SubjectVaccines & Immunisation
- BylineArticles whose byline prints “Rania Abdel Hay”